Carol M. Dutkowski

635 total citations
14 papers, 544 citations indexed

About

Carol M. Dutkowski is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Carol M. Dutkowski has authored 14 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in Carol M. Dutkowski's work include HER2/EGFR in Cancer Research (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Estrogen and related hormone effects (5 papers). Carol M. Dutkowski is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Estrogen and related hormone effects (5 papers). Carol M. Dutkowski collaborates with scholars based in United Kingdom, Austria and Australia. Carol M. Dutkowski's co-authors include Denise Barrow, Robert I. Nicholson, Julia M.W. Gee, Richard A. McClelland, Janice M. Knowlden, Tracie‐Ann Madden, Alan E. Wakeling, L. Morgan, Stephen Hiscox and Helen Jones and has published in prestigious journals such as PLoS ONE, Cancer Research and Endocrinology.

In The Last Decade

Carol M. Dutkowski

13 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol M. Dutkowski United Kingdom 9 329 287 188 87 86 14 544
Lanfang Qin United States 8 301 0.9× 235 0.8× 152 0.8× 87 1.0× 108 1.3× 14 528
Annabell S. Oh United States 12 395 1.2× 277 1.0× 325 1.7× 55 0.6× 118 1.4× 13 615
Kathleen Meeke United States 8 266 0.8× 250 0.9× 275 1.5× 47 0.5× 92 1.1× 8 516
R. Callies Germany 13 309 0.9× 185 0.6× 118 0.6× 71 0.8× 85 1.0× 30 527
P. Cannon United Kingdom 7 181 0.6× 294 1.0× 183 1.0× 53 0.6× 123 1.4× 10 496
Aisling M. Redmond United Kingdom 14 405 1.2× 200 0.7× 223 1.2× 86 1.0× 196 2.3× 18 665
M Dowsett United Kingdom 9 239 0.7× 277 1.0× 321 1.7× 63 0.7× 165 1.9× 11 515
Charlotte Andrieu France 8 207 0.6× 178 0.6× 116 0.6× 38 0.4× 154 1.8× 12 441
Kojiro Mashino Japan 6 300 0.9× 195 0.7× 86 0.5× 99 1.1× 85 1.0× 9 438
Astrid Balkenende Netherlands 5 274 0.8× 237 0.8× 186 1.0× 68 0.8× 85 1.0× 6 442

Countries citing papers authored by Carol M. Dutkowski

Since Specialization
Citations

This map shows the geographic impact of Carol M. Dutkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol M. Dutkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol M. Dutkowski more than expected).

Fields of papers citing papers by Carol M. Dutkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol M. Dutkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol M. Dutkowski. The network helps show where Carol M. Dutkowski may publish in the future.

Co-authorship network of co-authors of Carol M. Dutkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Carol M. Dutkowski. A scholar is included among the top collaborators of Carol M. Dutkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol M. Dutkowski. Carol M. Dutkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gee, Julia M.W., Mei Meng, Richard A. McClelland, et al.. (2015). Abstract P3-05-19: A new cell panel to study oestrogen receptor loss in acquired endocrine resistant breast cancer. Cancer Research. 75(9_Supplement). P3–5. 1 indexed citations
2.
Jordan, Nicola, Carol M. Dutkowski, Denise Barrow, et al.. (2014). Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Research. 16(1). R12–R12. 61 indexed citations
3.
Gee, Julia M.W., Lindy Goddard, Rajpal S. Burmi, et al.. (2014). Abstract 738: Increased Ret signalling and impact of vandetanib in acquired tamoxifen resistant breast cancer. Cancer Research. 74(19_Supplement). 738–738.
4.
Stone, Andrew, Fátima Valdés‐Mora, Julia M.W. Gee, et al.. (2012). Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer. PLoS ONE. 7(7). e40466–e40466. 52 indexed citations
5.
Gee, Julia M.W., Robert I. Nicholson, Denise Barrow, et al.. (2011). Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance. Hormone Molecular Biology and Clinical Investigation. 5(2). 67–77. 6 indexed citations
6.
7.
Hiscox, Stephen, L. Morgan, Denise Barrow, et al.. (2004). Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839). Clinical & Experimental Metastasis. 21(3). 201–212. 93 indexed citations
8.
Harper, M. E., Lindy Goddard, Jean W. Assender, et al.. (2002). Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor. The Prostate. 52(1). 59–68. 17 indexed citations
9.
Jones, Helen, Denise Barrow, Carol M. Dutkowski, et al.. (2001). Effect of an EGF‐R selective tyrosine kinase inhibitor and an anti‐androgen on LNCaP cells: Identification of divergent growth regulatory pathways. The Prostate. 49(1). 38–47. 14 indexed citations
10.
McClelland, Richard A., Denise Barrow, Tracie‐Ann Madden, et al.. (2001). Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)*. Endocrinology. 142(7). 2776–2788. 219 indexed citations
11.
12.
Jones, Helen, Colby L. Eaton, Denise Barrow, Carol M. Dutkowski, & K. Griffiths. (1997). Response of cell growth and retinoic acid receptor expression to retinoic acid in neoplastic and non-neoplastic prostate cell lines. The Prostate. 30(3). 174–182. 15 indexed citations
13.
Jones, Helen, Carol M. Dutkowski, Denise Barrow, et al.. (1997). New EGF‐R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC‐3 and DU‐145. International Journal of Cancer. 71(6). 1010–1018. 2 indexed citations
14.
Jones, Helen, Carol M. Dutkowski, Denise Barrow, et al.. (1997). New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145. International Journal of Cancer. 71(6). 1010–1018. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lanfang Qin Breakdown of academic impact, for papers by Annabell S. Oh Breakdown of academic impact, for papers by Kathleen Meeke Breakdown of academic impact, for papers by R. Callies Breakdown of academic impact, for papers by P. Cannon Breakdown of academic impact, for papers by Aisling M. Redmond Breakdown of academic impact, for papers by M Dowsett Breakdown of academic impact, for papers by Charlotte Andrieu Breakdown of academic impact, for papers by Kojiro Mashino Breakdown of academic impact, for papers by Astrid Balkenende
Rankless by CCL
2026